SBIR Banner

NCI SBIR provides 
funding, mentoring & networking assistance
for small businesses with next-generation cancer technologies.

What are the NCI SBIR & STTR Programs?

The SBIR & STTR Programs are one of the largest sources of early stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities.

 Learn more about the programs >

Resources For

The NCI also provides funding opportunities for specific cancer technology projects.

Click to view additional NCI Resources and Collaborative Programs >

Success Stories

Learn how NCI SBIR & STTR Programs have helped small businesses with funding awards that help advance cancer research.

AntiCancer, the San Diego-based biotechnology company, was awarded Phase I and II SBIR grants and contracts that have led to the commercialization of three cancer research tools: MetaMouse®, AngioMouse®, and OncoBrite®.

Developed LuViva, a non-invasive medical device designed to instantly detect cervical disease in a point-of-care setting with a $2.5 million Bridge Award.

Entrepreneurial Training

Learn about the entrepreneurial programs and training available.

Latest Announcements

FY18 HHS SBIR Contracts Solicitation is now available. Visit our Current Contracts page to view the list of 12 new contract topics.

The new Funding Opportunity Announcements (FOA) for 2017 Omnibus Soliciation are now available for both SBIR and STTR! Next receipt date is September 5, 2017. For more information, visit Omnibus Solicitations page.

SBIR Phase IIB Bridge Award for 2017 now available! (RFA-CA-17-024) Application receipt date is July 6, 2017. For more information, visit our Bridge Award page

New FOAs: Development of Highly Innovative Tools and Technology for Analysis of Single Cells (PA-17-147/148) [MORE INFO]

New NIH notices on RFIs and direct cost now available on NOTICES page.

Featured Video

Learn more about I-Corps at NIH

View more videos